Resources
About Us
Home Report
Store
Digital Biomanufacturing Market
Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software [PAT, MES, Digital Twin] Hardware), Functionality (Product Design, Analytics, Automation), Application (MAB, Protein, Vaccine), and Bioprocess - Global Forecast to 2031
Report ID:MRHC - 1041288 Pages: 300 Sep-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursDigital Biomanufacturing Market Size & Forecast
The Digital Biomanufacturing Market is projected to reach $50.89 billion by 2031 at a CAGR of 13.3% from 2024 to 2031. The growth of this market is attributed to various factors such as growing demand for biologics, capacity expansions of biopharmaceutical plants by key players, increased need for process optimization, growing focus on quality standards & regulatory compliance, strong R&D pipeline for biopharmaceuticals, and rising emphasis on continuous bioprocessing. Additionally, the introduction of Industry 4.0, availability of advanced data analysis tools, and shift towards bioprocessing 4.0 are expected to offer growth opportunities.
Digital Biomanufacturing Market Growth Drivers
Need for Process Optimization in Biomanufacturing
Process optimization involves improving manufacturing by incorporating quality monitoring, machinery, and maintenance, among other factors, to optimize costs and increase productivity. The biomanufacturing process is enhanced by process optimization through the identification and resolution of bottlenecks and the assurance of product quality. Process optimization techniques like design of experiments (DoE), statistical process control (SPC), and process analytical technology (PAT), assist biomanufacturers in reducing manufacturing costs and time for the biologics production by incorporating real time monitoring, continuous processing, and data capturing & analysis.
Biomanufacturing is an expensive method due to the need for specific culture conditions, costly media, and feed. The rising preference for biopharmaceuticals is driving the increased need for process optimization to achieve better yield and product quality. Thus, to scale up the business and to meet growing market demand biopharmaceutical manufacturers are increasing the adoption of process optimization techniques.
Click here to: Get Free Sample Pages of this Report
Rising Focus on Continuous Bioprocessing
The adoption of continuous bioprocessing is being driven by the rising demand for biopharmaceuticals, supportive global initiatives for their adoption, and the advantages of continuous bioprocessing over traditional batch processing. Continuous bioprocessing facilities are at least 70% smaller than batch production facilities, leading to reduced operating costs. Additionally, continuous bioprocessing alleviates bottlenecks in the manufacturing process, which increases production efficiency and, consequently, lowers the price of biopharmaceuticals.
Government initiatives, supporting the adoption of biopharmaceuticals, are driving the demand for continuous bioprocessing. For instance, in September 2022, the U.S. government announced an investment of USD 2 billion in a biomanufacturing initiative aimed at expanding and improving the domestic biopharmaceutical manufacturing capacity. The benefits of continuous bioprocessing, such as shorter product development times and enhanced process design flexibility, are driving its increasing adoption.
Digital Biomanufacturing Market Trends
Digital Twin Technology
Digital twin technology helps in predicting and optimizing maintenance for biomanufacturing process and facilities. It provides real-time visualization of products, processes, and their performances. This technology enables real-time monitoring through simulation, ensuring product quality and cost reduction by identifying defects in the ongoing manufacturing process. This enhances manufacturing planning and risk analysis.
Digital twin technology ensures that the planned process is proceeding as intended, maintaining time efficiency and process optimization through the implementation of effective strategies. For instance, Dassault Systèmes SE (France) offers a Virtual Twin for the biomanufacturing industry. The product provides a digital replica of the pharmaceutical process to optimize and predict the biomanufacturing process. It also helps in the resource planning, building manufacturing plants, simulating & analyzing production scenarios, and unify manufacturing operations.
Integration of Artificial Intelligence (AI) & Machine Learning (ML)
Integration of advanced technologies like AI & ML improves monitoring and controlling of the entire manufacturing process. AI & ML assist in drug discovery, design & development, as well as planning and monitoring product quality. They enhance process optimization and resource management throughout the process. AI helps in structuring data and workflow of the machines & equipment involved in the manufacturing process.
ML helps in various processes like design and planning of biologics, connecting it to actual manufacturing process, and increasing efficiency of working models. For instance, in July 2022, EMBL-European Bioinformatics Institute (EBI), a part of the European Molecular Biology Laboratory developed AlphaFold, AI system in collaboration with Google DeepMind to provide predictive 3D protein structures. This helps in forecasting of upcoming activities, risk analysis, decision making, and being preemptive for further execution.
Digital Biomanufacturing Market Opportunity
Shift Towards Bioprocessing 4.0
The biopharmaceutical industry is shifting towards Bioprocessing 4.0 (a term derived from Industry 4.0), a national strategic initiative launched by the German government in 2010. Biomanufacturing 4.0 is still in its initial stage. Bioprocessing 4.0 is defined as an end-to-end connected bioprocess, where all equipment and systems in the process are connected digitally through the industrial-internet-of-things (IIoT) to run, control, and enhance processes through feedback loops, machine learning, and artificial intelligence (AI). Digital transformation has become necessary in the biopharmaceutical industry as it provides the competitive advantage and opportunity for streamlining the production process. Digital biomanufacturing uses IoT to connect different data sources, equipment, and materials for process optimization. In combination with digital biomanufacturing solutions the adoption of bioprocessing 4.0 is gradually increasing. Many biopharmaceutical manufactures are shifting towards bioprocessing 4.0 to reduce the manual intervention during drug testing and monitoring which saves time and reduces the risk of errors and cross-contamination, thus boosting production.
Digital Biomanufacturing Market Analysis: Key Findings
By Offering: The Software Segment to Dominate the Digital Biomanufacturing Market in 2024
Based on offering, the digital biomanufacturing market is segmented into software and hardware. In 2024, the software segment is expected to account for the largest share of 74.4% of digital biomanufacturing market. Software used in bioprocessing such as manufacturing execution systems (MES), process analytical technology (PAT), digital twin and data analysis software (DAS) help in designing and planning of drug or biologics from development to manufacturing. The software also provides process monitoring and control with simulation techniques, predictive outcomes, risk analysis, and decision making. The usage of software in the entire biomanufacturing process is contributing to the largest share of the market.
Additionally, the rising demand of biologics and recent approvals for biologics, increasing R&D activities across biotechnology industry, increasing funding for biopharmaceutical development are supporting the largest share of software.
By Functionality: The Process Optimization & Analytics Segment to Dominate the Digital Biomanufacturing Market in 2024
Based on functionality, the digital biomanufacturing market is segmented into product design, process optimization & analytics, automation & control, and other applications. In 2024, the process optimization & analytics segment is expected to account for the largest share of digital biomanufacturing market. Process optimization and analytics technology help biomanufacturing companies in removing halts during the manufacturing process by controlling the parameters such as pH, temperature, and others which affect final quality of product. Process optimization functionalities tools have proven to be beneficial for the biomanufacturers for increasing efficiency and improving product quality, reducing waste, increasing flexibility and profitability. Thus, the adoption of process optimization & analytics solutions is highest among end-users.
By Bioprocess: The Downstream Bioprocess Segment to Dominate the Digital Biomanufacturing Market, in 2024
Based on bioprocess, the digital biomanufacturing market is segmented into upstream bioprocess and downstream bioprocess. In 2024, the downstream bioprocess segment is expected to account for the largest share of the digital biomanufacturing market. Downstream bioprocesses are complex and time-consuming activities which delays the product to reach the market. Also, downstream processing is considered as a crucial step for the recovery and purification of biologics. Recovery process can be affected by change in temperature and pH, hence digital biomanufacturing solutions are employed for the real-time monitoring of downstream process. Additionally, digital biomanufacturing solutions provide predictive control over the downstream process by calculating process deviations based on gathered data. Thus, it helps maintaining the stability of the process and accelerates production, hence the demand for digital biomanufacturing in downstream bioprocess is increasing.
By Application: The Monoclonal Antibodies Segment to Dominate the Digital Biomanufacturing Market in 2024
Based on application, the digital biomanufacturing market is segmented into monoclonal antibodies, recombinant hormones/proteins, vaccines, cellular-based biologics, and gene-based biologics. In 2024, the monoclonal antibodies segment is expected to account for the largest share of 48.6% of the digital biomanufacturing market. Increasing funding for monoclonal antibody development, increasing approvals for monoclonal antibody, and increasing production capacity of monoclonal antibody are contributing to the largest share of the segment. The diagnostic use of monoclonal antibody has grown over the years owing to the rising number of approvals and increasing manufacturing capacity, and is further expected to increase with the introduction of Bioprocessing 4.0. As Bioprocessing 4.0 uses digital biomanufacturing solutions to run, control, and enhance processes, the manufacturing of monoclonal antibody is expected to increase.
By End User: The Biopharmaceutical Companies Segment to Dominate the Digital Biomanufacturing Market in 2024
Based on end-user, the digital biomanufacturing market is segmented into biopharmaceutical companies, academic and research institutes, and CDMO & CROs. In 2024, the biopharmaceutical companies segment is expected to account for the largest share of digital biomanufacturing market. The increasing preference for biopharmaceuticals, increasing research in personalized medicines, and supportive initiatives for the adoption of biopharmaceuticals are supporting the segment’s largest market share. Biopharmaceuticals are typically complex and costlier than the conventional drugs to manufacture. To reduce the errors in manufacturing and scale-up production process, biomanufacturing industries are deploying digital solutions to increase the production of biologics. The increasing number of biopharmaceutical companies along with gradually increasing adoption of digital technologies in biopharmaceutical companies is contributing to the largest share of the segment. For instance, around 55% of companies incorporated digital technologies in the workflow. (Source: Global Pharma Tek, U.S.)
Geographical Analysis
North America to Dominate the Market in 2024
In 2024, North America is expected to account for the largest share of digital biomanufacturing market. The largest share of the region is attributed to the developed healthcare infrastructure, adoption of advanced technologies, and increased investment in biopharmaceutical industry. The presence of key biopharmaceutical companies, contract development, manufacturing firms, and supportive initiatives by government are the key factor contributing to the share of digital biomanufacturing market in North America. Many of the key players are increasing the production capacity of biopharmaceuticals, thus increasing the demand for digital biomanufacturing solutions. For instance, in February 2024 Moderna, Inc. (U.S.), a pharmaceutical and biotechnology company in collaboration with the government of Canada completed the construction of new state-of-the-art mRNA vaccine production facility in Laval, Canada.
Moreover, the market in Asia-Pacific is slated to register the highest growth rate of 15.1% during the forecast period. The countries in Asia-Pacific, including China, India, and South Korea, are projected to offer significant growth opportunities for the vendors in this market. This is attributed to factors such as the rising number of biopharmaceutical companies, growing patient population, increasing disposable income, and rising foreign direct investments (FDI) for biopharmaceutical companies. In 2015, the Government of China unveiled the Made in China (MIC) 2025 plan aimed at bolstering the country's domestic manufacturing capabilities. This initiative has led to a surge in the emergence of new Chinese biopharmaceutical companies. Besides, China has emerged as an increasingly attractive R&D and manufacturing destination for international pharmaceutical companies trying to shorten product timelines and costs. Thus, the rising investment in the region’s biopharmaceutical industry is increasing the demand for digital biomanufacturing solutions thereby driving the market growth.
Digital Biomanufacturing Market: Key Companies
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years (2021–2024). The key players operating in the global digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (Subsidiary of Siemens) (Germany), Cytiva (Subsidiary of Danaher corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing Inc. (U.S.), Schneider Electric SE (France), Dassault Systèmes (France), Oracle Corporation (U.S.), and 3M (U.S.).
Digital Biomanufacturing Market Overview: Latest Developments from Key Industry Players
- In February 2023, AVEVA Group Limited (U.K.), launched AVEVA Manufacturing Execution System (MES) 2023, for use in the manufacturing industries for cost effective and time-saving manufacturing process.
- In December 2022, Tulip Interfaces, Inc. (U.S.), launched cloud-based Manufacturing Execution System (MES) in AWS solutions library to increase flexibility and scalability of the manufacturing process.
- In February 2022, HCL Technologies Limited (India), launched MVison framework to transform manufacturing processes via automation and digitalization with the help of technologies like augmented reality/virtual reality, connected devices, and artificial intelligence & machine learning.
Digital Biomanufacturing Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
300 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
13.3% |
|
Estimated Market Size (Value) |
$50.89 billion by 2031 |
|
Segments Covered |
By Offering
By Functionality
By Bioprocess
By Application
By End-user
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Ireland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa. |
|
Key Companies |
The key players operating in the global digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (subsidiary of Siemens) (Germany), Cytiva (subsidiary of Danaher Corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric Co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing. (U.S.), Schneider Electric SE (France), Dassault Systemes (France), Oracle Corporation (U.S.), and 3M (U.S.). |
Key questions answered in the digital biomanufacturing market report:
The global digital biomanufacturing market report covers the qualitative and quantitative analysis of the digital biomanufacturing market. This report involves the analysis of various segments of digital biomanufacturing such as offering, functionality, bioprocess, and end-user at the regional and country level. The report also provides insights on factors impacting market growth, regulatory analysis, pricing analysis, and Porter’s five forces analysis.
The global digital biomanufacturing market is projected to reach $50.89 billion by 2031 at a CAGR of 13.3% from 2024 to 2031.
Among all the offerings studied in this report, the software segment is expected to account for the largest share of 74.4% the digital biomanufacturing market, in 2024. The rising need for process optimization in the biomanufacturing industry is increasing the demand for software. Software deployment helps in evaluating product and process quality with real time monitoring, data management, and prediction-based outcomes. It helps to streamline the process of biomanufacturing.
The growth of this market can be attributed to several factors such as, growing demand for biologics, capacity expansions of biopharmaceutical plants by key players, increased need for process optimization, increased focus on quality standards & regulatory compliance, strong R&D pipeline for biopharmaceuticals, and rising focus on continuous bioprocessing. However, the excessive cost of technological deployment, complex development, and manufacturing process of biopharmaceuticals are restraining the market growth.
The key players operating in the global digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (subsidiary of Siemens) (Germany), Cytiva (subsidiary of Danaher Corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing. (U.S.), Schneider Electric SE (France), Dassault Systems (France), Oracle Corporation (U.S.), and 3M (U.S.).
The market in Asia-Pacific is slated to register the highest growth rate of 15.1% during the forecast period. The countries in Asia-Pacific, including China, India, and South Korea, are projected to offer significant growth opportunities for the vendors in this market. This is attributed to factors such as the rising number of biopharmaceutical companies, growing patient population, increasing disposable income, and rising foreign direct investments (FDI) for biopharmaceutical companies.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Growing Demand for Biologics
4.2.2. Capacity Expansions of Biopharmaceutical Plants by Key Players
4.2.3. Increased Need for Process Optimization
4.2.4. Increased Focus On Quality Standards & Regulatory Compliance
4.2.5. Strong R&D Pipeline for Biopharmaceuticals
4.2.6. Rising Focus on Continuous Bioprocessing
4.3. Restraints
4.3.1. High Cost of Technology Deployment
4.3.2. Complex Development and Manufacturing Process of Biopharmaceuticals
4.4. Opportunities
4.4.1. Introduction of Industry 4.0
4.4.2. Availability of Advanced Data Analysis Tools
4.4.3. Shift Towards Bioprocessing 4.0
4.5. Challenges
4.5.1. Complexities in Process Analytical Technology (PAT) Implementation for Downstream Processes.
4.5.2. Intensive Capital Requirements for Biopharmaceuticals Production
4.6. Factor Analysis
4.7. Trends
4.7.1. Digital Twin Technology
4.7.2. Integration of Artificial Intelligence (AI) & Machine Learning (ML)
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Porter’s Five Force Analysis
5. Digital Biomanufacturing Market Assessment—by Offering
5.1. Overview
5.2. Software
5.2.1. By Type
5.2.1.1. Process Analytical Technology
5.2.1.2. Data Analysis Software
5.2.1.3. Manufacturing Execution System
5.2.1.4. Digital Twin
5.2.2. By Deployment
5.2.2.1. Cloud-based
5.2.2.2. On-Premises
5.3. Hardware
6. Digital Biomanufacturing Market Assessment—by Functionality
6.1. Overview
6.2. Product Design
6.3. Process Optimization & Analytics
6.4. Automation & Control
6.5. Other Functionalities
7. Digital Biomanufacturing Market Assessment—by Bioprocess
7.1. Overview
7.2. Upstream Bioprocessing
7.3. Downstream Bioprocessing
8. Digital Biomanufacturing Market Assessment—by Application
8.1. Overview
8.2. Monoclonal Antibodies
8.3. Recombinant Hormones/Proteins
8.4. Vaccines
8.5. Cellular-based Biologics
8.6. Gene-based Biologics
9. Digital Biomanufacturing Market Assessment—by End-user
9.1. Overview
9.2. Biopharmaceutical Companies
9.3. Academic and Research Institutes
9.4. CDMOs & CROs
10. Digital Biomanufacturing Market Assessment—by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Switzerland
10.3.7. Denmark
10.3.8. Ireland
10.3.9. Belgium
10.3.10. Rest of Europe (RoE)
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America (RoLATAM)
10.6. Middle East & Africa
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Ranking, by Key Players (2023)
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
12.1. GE Healthcare Technologies, Inc.
12.2. Siemens Xcelerator (subsidiary of Siemens)
12.3. Cytiva (subsidiary of Danaher Corporation)
12.4. ABB Ltd. (Sweden)
12.5. Sanofi S.A.
12.6. Emerson Electric Co.
12.7. Honeywell International, Inc.
12.8. SAP SE
12.9. OVO Biomanufacturing Ltd.
12.10. Schneider Electric SE
12.11. Dassault Systèmes
12.12. Oracle Corporation
12.13. 3M
(Note: SWOT analysis of the top 5 companies will be provided.)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Global Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 2 Global Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 3 Global Digital Biomanufacturing software Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Process Analytical Technology Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Data Analysis Software Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Manufacturing execution System Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Digital Twin Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Digital Biomanufacturing Software Market, by Deployment, 2022–2031 (USD Million)
Table 9 Global Cloud-based Digital Biomanufacturing Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global On-Premises Digital Biomanufacturing Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Digital Biomanufacturing Hardware Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 13 Global Digital Biomanufacturing Market for Product Design Functionality, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Digital Biomanufacturing Market for Process Optimization & Analytics, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Digital Biomanufacturing Market for Automation & Control, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Digital Biomanufacturing Market for Other Functionalities, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 18 Global Digital Biomanufacturing Market for Upstream Bioprocessing, by Country/ Region, 2022–2031 (USD Million)
Table 19 Global Digital Biomanufacturing Market for Downstream Bioprocessing, by Country/ Region, 2022–2031 (USD Million)
Table 20 Global Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 21 Global Digital Biomanufacturing Market for Monoclonal Antibodies, by Country/ Region, 2022–2031 (USD Million)
Table 22 Global Digital Biomanufacturing Market for Recombinant Hormones/Proteins, by Country/ Region, 2022–2031 (USD Million)
Table 23 Global Digital Biomanufacturing Market for Vaccines, by Country/ Region, 2022–2031 (USD Million)
Table 24 Global Digital Biomanufacturing Market for Cellular-based Biologics Market, by Country/ Region, 2022–2031 (USD Million)
Table 25 Global Digital Biomanufacturing Market Gene-based Biologics, by Country/ Region, 2022–2031 (USD Million)
Table 26 Global Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 27 Global Digital Biomanufacturing Market for Biopharmaceutical Companies, by Country/ Region, 2022–2031 (USD Million)
Table 28 Global Digital Biomanufacturing Market for Academic and Research Institutes, by Country/ Region, 2022–2031 (USD Million)
Table 29 Global Digital Biomanufacturing Market for CDMOs &CROs, by Country/ Region, 2022–2031 (USD Million)
Table 30 Global Digital Biomanufacturing Market, by Country/ Region, 2022–2031 (USD Million)
Table 31 North America: Digital Biomanufacturing Market, by Country, 2022-2031 (USD Million)
Table 32 North America: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 33 North America: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million
Table 34 North America: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 35 North America: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 36 North America: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 37 North America: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 38 North America: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 39 U.S.: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 40 U.S.: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 41 U.S.: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 42 U.S.: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 43 U.S.: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 44 U.S.: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 45 U.S.: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 46 Canada: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 47 Canada: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 48 Canada: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 49 Canada: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 50 Canada: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 51 Canada: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 52 Canada: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 53 Europe: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
Table 54 Europe: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 55 Europe: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 56 Europe: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 57 Europe: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 58 Europe: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 59 Europe: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 60 Europe: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 61 Germany: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 62 Germany: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 63 Germany: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 64 Germany: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 65 Germany: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 66 Germany: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 67 Germany: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 68 U.K.: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 69 U.K.: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 70 U.K.: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 71 U.K.: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 72 U.K.: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 73 U.K.: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 74 U.K.: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 75 Italy: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 76 Italy: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 77 Italy: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 78 Italy: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 79 Italy: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 80 Italy: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 81 Italy: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 82 Spain: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 83 Spain: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 84 Spain: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 85 Spain: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 86 Spain: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 87 Spain: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 88 Spain: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 89 Switzerland: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 90 Switzerland: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 91 Switzerland: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 92 Switzerland: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 93 Switzerland: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 94 Switzerland: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 95 Switzerland: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 96 Denmark: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 97 Denmark: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 98 Denmark: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 99 Denmark: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 100 Denmark: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 101 Denmark: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 102 Denmark: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 103 Ireland: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 104 Ireland: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 105 Ireland: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 106 Ireland: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 107 Ireland: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 108 Ireland: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 109 Ireland: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 110 Belgium: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 111 Belgium: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 112 Belgium: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 113 Belgium: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 114 Belgium: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 115 Belgium: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 116 Belgium: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 117 Rest of Europe: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 118 Rest of Europe: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 119 Rest of Europe: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 120 Rest of Europe: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 121 Rest of Europe: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 122 Rest of Europe: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 123 Rest of Europe: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 124 Asia-Pacific: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
Table 125 Asia-Pacific: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 126 Asia-Pacific: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 127 Asia-Pacific: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 128 Asia-Pacific: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 129 Asia-Pacific: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 130 Asia-Pacific: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 131 Asia-Pacific: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 132 Japan: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 133 Japan: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 134 Japan: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 135 Japan: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 136 Japan: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 137 Japan: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 138 Japan: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 139 China: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 140 China: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 141 China: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 142 China: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 143 China: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 144 China: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 145 China: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 146 India: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 147 India: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 148 India: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 149 India: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 150 India: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 151 India: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 152 India: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 153 Australia: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 154 Australia: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 155 Australia: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 156 Australia: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 157 Australia: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 158 Australia: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 159 Australia: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 160 South Korea: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 161 South Korea: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 162 South Korea: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 163 South Korea: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 164 South Korea: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 165 South Korea: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 166 South Korea: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 167 Rest of Asia-Pacific: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 168 Rest of Asia-Pacific: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 169 Rest of Asia-Pacific: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 170 Rest of Asia-Pacific: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 171 Rest of Asia-Pacific: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 172 Rest of Asia-Pacific: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 173 Rest of Asia-Pacific: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 174 Latin America: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
Table 175 Latin America: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 176 Latin America: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 177 Latin America: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 178 Latin America: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 179 Latin America: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 180 Latin America: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 181 Latin America: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 182 Brazil: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 183 Brazil: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 184 Brazil: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 185 Brazil: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 186 Brazil: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 187 Brazil: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 188 Brazil: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 189 Mexico: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 190 Mexico: Digital Biomanufacturing software Market, by Type, 2022–2031 (USD Million)
Table 191 Mexico: Digital Biomanufacturing software Market, by Deployment, 2022–2031 (USD Million)
Table 192 Mexico: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 193 Mexico: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 194 Mexico: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 195 Mexico: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 196 Rest of Latin America: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 197 Rest of Latin America: Digital Biomanufacturing Software Market, by Type, 2022–2031 (USD Million)
Table 198 Rest of Latin America: Digital Biomanufacturing Software Market, by Deployment, 2022–2031 (USD Million)
Table 199 Rest of Latin America: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 200 Rest of Latin America: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 201 Rest of Latin America: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 202 Rest of Latin America: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 203 Middle East & Africa: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
Table 204 Middle East & Africa: Digital Biomanufacturing Market, by Offering, 2022–2031 (USD Million)
Table 205 Middle East & Africa: Digital Biomanufacturing Software Market, by Type, 2022–2031 (USD Million)
Table 206 Middle East & Africa: Digital Biomanufacturing Software Market, by Deployment, 2022–2031 (USD Million)
Table 207 Middle East & Africa: Digital Biomanufacturing Market, by Functionality, 2022–2031 (USD Million)
Table 208 Middle East & Africa: Digital Biomanufacturing Market, by Bioprocess, 2022–2031 (USD Million)
Table 209 Middle East & Africa: Digital Biomanufacturing Market, by Application, 2022–2031 (USD Million)
Table 210 Middle East & Africa: Digital Biomanufacturing Market, by End-user, 2022–2031 (USD Million)
Table 211 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Digital Biomanufacturing Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 8 Global Digital Biomanufacturing Market, by Functionality, 2024 VS. 2031 (USD Million)
Figure 9 Global Digital Biomanufacturing Market, by Bioprocess, 2024 VS. 2031 (USD Million)
Figure 10 Global Digital Biomanufacturing Market, by Application, 2024 VS. 2031 (USD Million)
Figure 11 Global Digital Biomanufacturing Market, by End-user, 2024 VS. 2031 (USD Million)
Figure 12 Global Digital Biomanufacturing Market, by Geography
Figure 13 Impact Analysis of Market Dynamics
Figure 14 Global Digital Biomanufacturing Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 15 Global Digital Biomanufacturing Market, by Functionality, 2024 VS. 2031 (USD Million)
Figure 16 Global Digital Biomanufacturing Market, by Bioprocess, 2024 VS. 2031 (USD Million)
Figure 17 Global Digital Biomanufacturing Market, by Application, 2024 VS. 2031 (USD Million)
Figure 18 Global Digital Biomanufacturing Market, by End-user, 2024 VS. 2031 (USD Million)
Figure 19 Global Digital Biomanufacturing Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 20 North America: Digital Biomanufacturing Market Snapshot
Figure 21 Europe: Digital Biomanufacturing Market Snapshot
Figure 22 Asia-Pacific: Digital Biomanufacturing Market Snapshot
Figure 23 Latin America: Digital Biomanufacturing Market Snapshot
Figure 24 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 25 Global Digital Biomanufacturing Market: Competitive Benchmarking, by Offering
Figure 26 Global Digital Biomanufacturing Market: Competitive Benchmarking, by Geography
Figure 27 Global Digital Biomanufacturing Market: Competitive Dashboard
Figure 28 Global Digital Biomanufacturing Market: Market Share Analysis/Market Ranking, By Key Players (2023)
Figure 29 GE Healthcare Technologies, Inc.: Financial Snapshot (2023)
Figure 30 Siemens AG: Financial Snapshot (2023)
Figure 31 Danaher Corporation: Financial Snapshot (2023)
Figure 32 ABB Ltd.: Financial Snapshot (2023)
Figure 33 Sanofi S.A.: Financial Snapshot (2023)
Figure 34 Emerson Electric co.: Financial Snapshot (2023)
Figure 35 Honeywell International, Inc.: Financial Snapshot (2023)
Figure 36 SAP SE: Financial Snapshot (2023)
Figure 37 Schneider Electric SE: Financial Snapshot (2023)
Figure 38 Dassault Systèmes: Financial Snapshot (2023)
Figure 39 Oracle Corporation: Financial Snapshot (2023)
Figure 40 3M: Financial Snapshot (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Digital X-ray Systems Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jul-2024
Digital Health Market - Global Opportunity Analysis and Industry Forecasts (2024-2031)
Published Date: May-2024
Digital Diabetes Market - Global Opportunity Analysis and Industry Forecast (2018 - 2025)
Published Date: Feb-2019
X-Ray Detectors Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: May-2024
Digital Therapeutics Market - Global Opportunity Analysis And Industry Forecast (2024-2031)
Published Date: Nov-2024
